Archive for November 11th, 2008

After-hours Gapper: MercadoLibre (MELI)

MercadoLibre, Inc. (NASDAQ: MELI) beat earnings in after-hours trading but did not offer formal guidance.  Until this conference call is finished it should be considered unfinished business. Shares are up over 9.5% at $11.32 in after-hours on over 20,000 shares… after an 11% drop today and after about an 85% drop from its late 2007 [...]

Price/Volume Alert: Gafisa S.A. (GFA, TOL)

Gafisa S.A. (NYSE: GFA), the Brazilian homebuilder was delayed on opening this morning.  There was increased selling in Brazil today, and it probably didn’t help that Toll Brothers (NYSE: TOL) in the U.S. said that the company cannot predict a profit in fiscal 2009. This expected home weakness is sort of mind boggling that anyone [...]

Sympathy Trade Alert: VisionChina Media (VISN, FMCN)

VisionChina Media Inc. (NASDAQ: VISN) traded lower in after-hours trading last night, but on very thin volume.  The reason is simple: it is a small advertising competitor to Focus Media (NASDAQ: FMCN). We have not seen any trades this morning, but the price indications are down 2% to 4% as a result.  If Focus media [...]

Price Volume Alerts: Macau Casino Plays (LVS, WYNN, MPEL)

Casino stocks, particularly those with a Macau angle are active in trading today.  There are concerns that Singapore’s government will enter a venture to take over the Las Vegas Sands Corp. (NYSE: LVS) resort in Macau if the company is unable to fight off loan defaults. As Wynn Resorts (NASDAQ: WYNN) is supposed to be [...]

Price/Volume Tanker: Focus Media (FMCN)

Focus Media Holding Ltd. (NASDAQ: FMCN), a Chinese advetising agency for online, outdoor, and print ads, is seeing its stock getting crushed this morning.  Shares are down 34% at $10.69 as 8:38 AM EST this morning after the company posted earnings.  Unfortunately it gave light earnings and issued weak guidance for the quarter ahead.  The [...]

Price Tanker: Sangamo (SGMO)

Sangamo Biosciences Inc. (NASDAQ: SGMO) is seeing its stock crushed this morning.  The biotech’s nerve drug aimed at treating diabetic pain failed a mid-stage trial. This has prompted at least two analyst downgrades this morning: Sangamo Cut to Neutral at Merriman Curhan Ford; Cut to Sell at Piper Jaffray. The small cap biotech is seeing [...]

Major Price/Volume Surge: Optimer Pharmaceuticals (OPTR)

Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) is soaring in early hours trading today.  The stock is indicated up 85% at $8.51 on almost 40,000 shares at 8:27 AM EST after the company said that its antibiotic to treat hospital (and long-term care and community) acquired infection met the main goal of achieving clinical cure.  Its results [...]